Portable Device Assesses Targeted Therapy’s Effectiveness

​Researchers have developed a portable system that quickly determines an individual patient's response to targeted cancer therapy. "Our technology combines artificial intelligence and sophisticated biosensors that handle tiny amounts of fluids to see if cancer cells are sensitive or resistant to chemotherapy drugs," commented Mehdi Javanmard, PhD, Assistant Professor of Electrical and Computer Engineering at Rutgers University–New Brunswick and senior author of the study, which has now been publ...
Continue reading

Subscribe

Get the latest updates delivered to your inbox!

Follow Us

Copyright © 2021 Oncology Data Advisor. All rights reserved.